Literature DB >> 2190784

Diurnal variation in glucose and leucine metabolism in non-insulin-dependent diabetes.

A M Umpleby1, I N Scobie, M A Boroujerdi, E R Carson, P H Sonksen.   

Abstract

Glucose and leucine metabolism were investigated in 5 poorly controlled non-insulin-dependent diabetics (NIDDM) following an i.v. injection of 3-[3H]glucose and 1-[14C]leucine in the morning and evening. In the morning glucose concentration (11.2 +/- 0.8 mmol/l) (mean +/- SEM) and production rate (14.2 +/- 1.3 mumol/min/kg) were significantly greater (P less than 0.001, P less than 0.05) and glucose metabolic clearance rate (MCR) (1.3 +/- 0.2 ml/min/kg) significantly lower (P less than 0.05) than in a group of control subjects. Glucose concentration was lower in the evening (P less than 0.05) as a result of a decrease in glucose production rate (P less than 0.05). Leucine concentration and production rate were not significantly different from normal but leucine oxidation rate was increased (P less than 0.05). There was no diurnal variation in leucine metabolism. Since leucine production is a measure of protein breakdown, the higher morning glucose production rate was not due to an increased supply of gluconeogenic precursors from protein catabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2190784     DOI: 10.1016/0168-8227(90)90014-k

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

Review 1.  Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.

Authors:  Sean H Adams
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

2.  Whole-body proteolysis rate is elevated in HIV-associated insulin resistance.

Authors:  Dominic N Reeds; W Todd Cade; Bruce W Patterson; William G Powderly; Samuel Klein; Kevin E Yarasheski
Journal:  Diabetes       Date:  2006-10       Impact factor: 9.461

3.  Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women.

Authors:  Oliver Fiehn; W Timothy Garvey; John W Newman; Kerry H Lok; Charles L Hoppel; Sean H Adams
Journal:  PLoS One       Date:  2010-12-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.